FINANCIAL NEWS

ASX Winners And Losers Of Today – 03-11-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

Nov 03 2026


Strong ResMed Result Comes With Caveats

RedMed posted a stronger than expected first quarter, although various contingencies were reflected in the result and the subsequent outlook

Nov 03 2026


Australian Broker Call *Extra* Edition – Nov 03, 2026

Extra Edition of the Broker Call Report

Nov 03 2026


Sold Off PLS Shares Ready To Rally

Michael Gable of Fairmont Equities reports PLS is showing signs of a potential rebound following a sharp sell-off

Nov 03 2026


Weekly Update On LICs & LITs – 02-Nov-2026

Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX

Nov 03 2026


Bell Potter rates CWP as Buy

Post Cedar Woods Properties's 1Q27 update, Bell Potter lowers EPS forecasts slightly on reduced settlement volume expectations due to the current weak residential sector.

The analyst lowers settlement forecasts by -1% for FY27 and -6% for FY28, with over 90% of revenue secured for FY27, the lag between sales and settlements means the current weak market conditions will not impact until FY28.

Forecast settlements are still expected to grow by 5% to 1,220 in FY28 and up 2.5% in FY29.

Target price eases to $9.45 from $9.60 with no change in Buy rating.

Morgans rates DYL as Speculative Buy

Despite Deep Yellow deferring FID for Tumas, Morgans notes the project is advancing, with detailed engineering now 85% complete and civil works underway.

Detailed design on the 220kV grid connection and development agreements with NamPower and NamWater are being negotiated.

The broker believes the market is underappreciating the value of a development-ready uranium asset with significant leverage to improving fundamentals.

Speculative Buy rating. Target is $1.50.

Macquarie rates NHF as Neutral

Macquarie highlights mixed first-quarter FY27 visa trends affecting nib Holdings' international health insurance (IHI) business.

Regulatory changes allowing more insurers into the Pacific Australia Labour Mobility scheme are expected to constrain future growth.

The broker estimates student visa grants relevant to nib declined -10% year-on-year, while worker visa holders increased 13%.

Commentary notes nib's student insurance is now the market's most expensive, while its worker insurance remains competitively priced.

Neutral rating and $6.60 target maintained.

Click here to see full report market arrow icon

ANALYSIS & DATA

FNARENA'S MARKET CONSENSUS FORECASTS

To display the stock analysis for a company please enter the company code:

ANZ | ANZ GROUP HOLDINGS LIMITED

Abbreviated format - see the full version here


LAST PRICECHANGE +/-CHANGE %VOLUME

$40.56

02 Nov
2026

market red arrow -0.250

OPEN

$40.66

market red arrow -0.61%

HIGH

$41.27

4,278,661

LOW

$40.17

TARGET
$36.073-11.1% downside
Franking for last dividend paid out: 75%
FNARENA'S MARKET CONSENSUS FORECASTS
ANZ: 1
TitleFY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps)xxx 198.2 247.9xxx
DPS (cps)xxx 166.0 166.7xxx
EPS Growthxxx- 9.1% 25.1%xxx
DPS Growthxxx 0.0% 0.4%xxx
PE RatioxxxN/A 16.3xxx
Dividend YieldxxxN/A 4.1%xxx
Div Pay Ratio(%)xxx 83.8% 67.2%xxx

FOLLOW US ON SOCIAL MEDIA

9.2K Followers
27.2K Posts
@Filapek
Rudi Filapek-Vandyck@Filapek
1h
Pimco: "From here, the trade-off facing the RBA becomes increasingly challenging. "With unemployment already at 4.7%, household spending weakening and the housing downturn deepening, further tightening would increase the risk of a more material slowdown in demand and,
@Filapek
Rudi Filapek-Vandyck@Filapek
3h
Citi on WiseTech Global $WTC: "Our analysis of industry air and sea freight volumes points to volumes being up yoy in the September quarter, with sea freight volumes up low-to-mid single digits and air freight up mid-single digits, according to DSV, slower vs. June quarter.
@Filapek
Rudi Filapek-Vandyck@Filapek
7h
CLSA previews Light & Wonder $LNW: "We expect a solid result for LNW in 3QCY26, forecasting AEBITDA growth of 4% YoY. "Our 3QCY26 AEBITDA forecasts reflect c.26% of our CY26 AEBITDA, consistent with LNW’s guidance for cadence to be similar with CY25. "As such we sit slightly
@Filapek
Rudi Filapek-Vandyck@Filapek
1d
Amazing how the market keeps treating ResMed $RMD... irrespective of how good the quarterly performance turns out to be... Tomorrow shall be the first day of sell-off recovery... yet again 😉#stockinfocus#ASX#investing
@Filapek
Rudi Filapek-Vandyck@Filapek
1d
Citi on Westpac $WBC: "WBC reported FY26 cash earnings of $6,992m, in-line with Citi/VA consensus expectations. "Revenue was ~0.5% below expectations, but mitigated by lower costs (~0.6%) and bad debts (~5% below). "NIM of 1.87% was 2bps below forecasts, implying a ~5bp
@Filapek
Rudi Filapek-Vandyck@Filapek
1d
RBC Capital on Endeavour Group $EDV: "1Q27 Group sales growth came in -70bps below RBCe/ -30bps below Cons. "Retail highlighted a back-end slowdown as sales began comping against lower shelf prices and elevated promotional activity in the pcp. "Hotels were broadly in line,
@Filapek
Rudi Filapek-Vandyck@Filapek
4d
RBC Capital on ResMed $RMD: "RMD delivered a strong 1Q27 which beat on revenues and gross margins. "While this result did benefit from the delayed phasing of supply chain investments and elevated RoW device sales that will roll-off in the 2H, we like the company's growth being
@Filapek
Rudi Filapek-Vandyck@Filapek
4d
RBC Capital on Coles Group $COL : "A disappointing update - we think the market will focus on 1) likely market share losses in Supermarkets with COL reporting +2.7% comp sales growth vs RBCe +3.2%, and further moderation in October compared to 1Q27 (current RBCe 2Q27 forecast is
@Filapek
Rudi Filapek-Vandyck@Filapek
4d
RBC Capital on ResMed $RMD: "RMD has delivered a strong result that has beat RBCe and consensus across all key line items. "The company has delivered strong revenue performance across all categories. "Non-GAAP gross margin expanded by 20bps sequentially, which beat
@Filapek
Rudi Filapek-Vandyck@Filapek
4d
Rudi's View: High Conviction ASX Opportunitieshttps://t.co/QowNhmaoX1#ASX#stocksinfocus#investing@FNArena
FIND FNARENA ON

DAILY FINANCIAL NEWS

Strong ResMed Result Comes With Caveats

RedMed posted a stronger than expected first quarter, although various contingencies were reflected in the result and the subsequent outlook

Nov 03 2026 - Australia


Michael Gable of Fairmont Equities reports PLS is showing signs of a potential rebound following a sharp sell-off

Nov 03 2026 - Technicals


Data#3’s strong start to FY27 has twice triggered upgrades to forecasts, now questions are being asked about the premium valuation

Nov 02 2026 - Small Caps


Woolworths management has made considerable headway in improving its offering to consumers, as reflected in a robust 1Q27 result, but analysts are questioning whether the momentum can be sustained

Nov 02 2026 - Australia


Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

Oct 31 2026 - Australia


While Zip Co’s fraud losses and rising US bad debts rattled investors, accelerating growth and unchanged guidance keep analysts positive

Oct 29 2026 - Small Caps


rudi fnarena picture

RUDI'S VIEWS

Rudi’s View: High Conviction ASX Opportunities

In this week’s edition: Fundies Selling Resources, Opportunities In Small Caps, Noosa Conference Standouts & December Index Changes

Oct 29 2026

DAILY MARKET REPORTS

ASX Winners And Losers Of Today – 03-11-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

Nov 03 2026


Australian Broker Call *Extra* Edition – Nov 03, 2026

Extra Edition of the Broker Call Report

Nov 03 2026


The Overnight Report: Positive Ahead Of RBA Hike

A global perspective on what happened overnight

Nov 03 2026


Today’s Financial Calendar – 03-11-2026

Significant Scheduled Events For 03 November, 2026

Nov 03 2026


ASX Winners And Losers Of Today – 02-11-26

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

Nov 02 2026


Australian Broker Call *Extra* Edition – Nov 02, 2026

Extra Edition of the Broker Call Report

Nov 02 2026


The Monday Report – 02 November 2026

Wrap of events affecting the market on Friday night and the weekend and a preview of the week ahead

Nov 02 2026


WEEKLY REPORTS

Weekly Update On LICs & LITs – 02-Nov-2026

Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX

Nov 03 2026

Uranium Week: U308 Momentum Up Sharply

After several quiet weeks, activity across U308 markets sprung to life, with sellers prepared to action transactions at higher prices

Nov 03 2026

Australian Listed Real Estate Tables – 02-11-2026

FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data

Nov 02 2026


Weekly Ratings, Targets, Forecast Changes – 30-10-26

Weekly update on stockbroker recommendation, target price, and earnings forecast changes

Nov 02 2026

Next Week At A Glance – 2-6 Nov 2026

A brief look at important company events and economic data releases next week

Oct 30 2026

In Case You Missed It – BC Extra Upgrades & Downgrades – 30-10-26

A summary of the highlights from Broker Call Extra updates throughout the week past

Oct 30 2026


Weekly Top Ten News Stories – 30 October 2026

Our top ten news stories from 22 October 2026 to 29 October 2026

Oct 30 2026

In Brief: Benz Mining, Cobram, Advanced Innergy

In this week’s In Brief, three initiations on a mega-scale WA gold developer, Australia’s premier olive oil producer, and an offshore energy materials specialist

Oct 30 2026

The Short Report – 29 Oct 2026

FNArena’s weekly update on short positions in the Australian share market

Oct 29 2026


9.2K Followers
27.2K Posts
@Filapek
Rudi Filapek-Vandyck @Filapek
12h
Pimco: "From here, the trade-off facing the RBA becomes increasingly challenging. "With unemployment already at 4.7%, household spending weakening and the housing downturn deepening, further tightening would increase the risk of a more material slowdown in demand and,
@Filapek
Rudi Filapek-Vandyck @Filapek
14h
Citi on WiseTech Global $WTC: "Our analysis of industry air and sea freight volumes points to volumes being up yoy in the September quarter, with sea freight volumes up low-to-mid single digits and air freight up mid-single digits, according to DSV, slower vs. June quarter.
@Filapek
Rudi Filapek-Vandyck @Filapek
19h
CLSA previews Light & Wonder $LNW: "We expect a solid result for LNW in 3QCY26, forecasting AEBITDA growth of 4% YoY. "Our 3QCY26 AEBITDA forecasts reflect c.26% of our CY26 AEBITDA, consistent with LNW’s guidance for cadence to be similar with CY25. "As such we sit slightly
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
Amazing how the market keeps treating ResMed $RMD... irrespective of how good the quarterly performance turns out to be... Tomorrow shall be the first day of sell-off recovery... yet again 😉 #stockinfocus #ASX #investing
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
Citi on Westpac $WBC: "WBC reported FY26 cash earnings of $6,992m, in-line with Citi/VA consensus expectations. "Revenue was ~0.5% below expectations, but mitigated by lower costs (~0.6%) and bad debts (~5% below). "NIM of 1.87% was 2bps below forecasts, implying a ~5bp
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
RBC Capital on Endeavour Group $EDV: "1Q27 Group sales growth came in -70bps below RBCe/ -30bps below Cons. "Retail highlighted a back-end slowdown as sales began comping against lower shelf prices and elevated promotional activity in the pcp. "Hotels were broadly in line,
@Filapek
Rudi Filapek-Vandyck @Filapek
4d
RBC Capital on ResMed $RMD: "RMD delivered a strong 1Q27 which beat on revenues and gross margins. "While this result did benefit from the delayed phasing of supply chain investments and elevated RoW device sales that will roll-off in the 2H, we like the company's growth being
@Filapek
Rudi Filapek-Vandyck @Filapek
4d
RBC Capital on Coles Group $COL : "A disappointing update - we think the market will focus on 1) likely market share losses in Supermarkets with COL reporting +2.7% comp sales growth vs RBCe +3.2%, and further moderation in October compared to 1Q27 (current RBCe 2Q27 forecast is
@Filapek
Rudi Filapek-Vandyck @Filapek
4d
RBC Capital on ResMed $RMD: "RMD has delivered a strong result that has beat RBCe and consensus across all key line items. "The company has delivered strong revenue performance across all categories. "Non-GAAP gross margin expanded by 20bps sequentially, which beat
@Filapek
Rudi Filapek-Vandyck @Filapek
5d
Rudi's View: High Conviction ASX Opportunities https://t.co/QowNhmaoX1 #ASX #stocksinfocus #investing @FNArena
FIND FNARENA ON

THE MARKETS

    Click item/line to change chart

  • Australia

    03 November 2026   Updated : 20:11   AEDT

    SPI Overnight

    8924.00

    +58.00

    0.65%

    NZ50

    13720.260

    +21.630

    0.160%

    All Ordinaries

    9008.90

    +31.70

    0.35%

    S&P ASX 200

    8886.80

    +30.30

    0.34%

    S&P ASX 300

    8792.00

    +29.10

    0.33%

    Communication Services

    1618.70

    +27.40

    1.72%

    Consumer Discretionary

    3776.90

    +69.40

    1.87%

    Consumer Staples

    13152.90

    +158.40

    1.22%

    Energy

    10662.70

    -381.20

    -3.45%

    Financials

    9802.30

    +40.70

    0.42%

    Health Care

    34313.60

    -201.60

    -0.58%

    Industrials

    8344.40

    +55.40

    0.67%

    Info Technology

    1630.10

    +12.40

    0.77%

    Materials

    21877.00

    -36.80

    -0.17%

    Real Estate

    3447.20

    +96.40

    2.88%

    Utilities

    10690.70

    -16.80

    -0.16%

    A-REITs

    1607.80

    +44.50

    2.85%

    All Technology Index

    2830.90

    +18.60

    0.66%

    Banks

    4127.80

    +11.80

    0.29%

    Gold Index

    16652.60

    +50.10

    0.30%

    Metals & Mining

    7450.10

    -19.30

    -0.26%

    Click item/line to change chart

  • Australasia

    03 November 2026   Updated : 20:11   AEDT

    AUD/USD

    0.6970

    -0.01

    -0.84%

    AUD/NZD

    1.2407

    -0.01

    -0.43%

    NZD/USD

    0.5617

    0.00

    -0.43%

    AUD/JPY

    110.15

    -0.66

    -0.60%

    SGD/AUD

    1.12

    +0.01

    0.59%

    AUD/EUR

    0.6227

    0.00

    -0.50%

    AUD/GBP

    0.5195

    0.00

    -0.65%

    AUDCAD

    0.9736

    -0.01

    -0.74%

  • World

    03 November 2026   Updated : 20:11   AEDT

    CAD/USD

    0.7159

    0.00

    -0.10%

    EUR/JPY

    176.87

    -0.21

    -0.12%

    EUR/USD

    1.1191

    0.00

    -0.37%

    GBP/USD

    1.3417

    0.00

    -0.19%

    USD/JPY

    158.04

    +0.39

    0.24%

    Click item/line to change chart

  • World

    03 November 2026   Updated : 20:11   AEDT

    FTSE100

    10713.05

    -48.28

    -0.45%

    DAX30

    25703.75

    -277.34

    -1.07%

    Hang Seng

    23525.97

    +132.65

    0.57%

    Nikkei 225

    63081.86

    -208.25

    -0.33%

    NZ50

    13720.260

    +21.630

    0.160%

    DJIA

    51983.98

    +213.67

    0.41%

    S&P500

    7541.40

    -38.67

    -0.51%

    Nasdaq Comp

    25164.36

    -272.63

    -1.07%

    S&P500 VIX

    21.80

    +2.38

    12.26%

    US 10-year yield

    4.894

    -0.035

    -0.710%

    USD Index

    101.76

    -0.20

    -0.20%

  • Aus Stocks

    03 November 2026   Updated : 20:11   AEDT

    Amcor (US)

    49.02

    +1.63

    3.44%

    Newmont (US)

    109.09

    +2.49

    2.34%

    Rio Tinto (UK)

    6110.00

    -86.00

    -1.39%

    BHP Group (US)

    80.07

    +0.89

    1.12%

    Rio Tinto (US)

    82.73

    +0.84

    1.03%

    ResMed (US)

    232.94

    +3.00

    1.30%

    South32 (UK)

    224.60

    -4.00

    -1.75%

    James Hardie (US)

    27.81

    +0.56

    2.06%

    Janus Henderson (US)

    51.95

    -0.02

    -0.04%

    Click item/line to change chart

  • Metals & Minerals

    03 November 2026   Updated : 08:17   AEDT

    Gold (oz)

    3946.13

    +70.29

    1.81%

    Silver (oz)

    50.49

    +1.59

    3.25%

    Copper (lb)

    6.5100

    +0.05

    0.77%

    Aluminium (lb)

    1.4129

    0.00

    0.00%

    Nickel (lb)

    6.9131

    0.00

    -0.02%

    Zinc (lb)

    1.7947

    0.00

    0.00%

    Copper (t)

    14348.04

    +110.20

    0.77%

    Aluminium (t)

    3114.00

    0.00

    0.00%

    Nickel (t)

    15236.50

    -3.50

    -0.02%

    Zinc (t)

    3955.50

    0.00

    0.00%

    Uranium (lb) weekly

    93.25

    +3.50

    3.90%

    Iron Ore (t)

    91.25

    +0.54

    0.60%

  • Energy

    03 November 2026   Updated : 08:17   AEDT

    West Texas Crude

    95.71

    -8.41

    -8.08%

    Brent Crude

    103.88

    -9.55

    -8.42%

CALENDAR

Wednesday, 4 November 2026
NZ 3Q Average hourly earnings q/q
NZ 3Q Employment change q/q
NZ 3Q Employment change y/y
NZ 3Q Participation rate
NZ 3Q Private wages excluding overtime
NZ 3Q Private wages including overtime
NZ 3Q Unemployment
AU Oct Composite PMI (final)
AU Oct PMI (final)
AU Oct Services PMI (final)
AU Sep Household spending
CH Oct PMI
CH Oct RatingDog composite PMI

ALL WEATHER STOCKS

CodeCompanyPrice
CARCAR GROUP LIMITED

market icon up$25.29

REAREA GROUP LIMITED

market icon up$166.16

RMDRESMED INC

market icon down$33.32

TNETECHNOLOGY ONE LIMITED

market icon up$31.85

WOWWOOLWORTHS GROUP LIMITED

market icon up$39.91

WEEKLY PDF

Stories To Read From FNArena


WEEK 44
icon pdf

WEEK 43
icon pdf

WEEK 42
icon pdf

WEEK 41
icon pdf

WEEK 40
icon pdf

FNARENA TALKS

FNARENA WINDOWS

Window on MEDICAL EQUIPMENT & DEVICES

Strong ResMed Result Comes With Caveats

RedMed posted a stronger than expected first quarter, although various contingencies were reflected in the result and the subsequent outlook

Nov 03 2026


Window on NEW BATTERY ELEMENTS

Sold Off PLS Shares Ready To Rally

Michael Gable of Fairmont Equities reports PLS is showing signs of a potential rebound following a sharp sell-off

Nov 03 2026


Window on WEALTH MANAGEMENT & INVESTMENTS

Weekly Update On LICs & LITs – 02-Nov-2026

Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX

Nov 03 2026


GEN AI

NextDC’s Collision With The Real World

The global AI infrastructure boom is colliding with real-world constraints, forcing NextDC to issue a shock profit warning last week

Oct 26 2026


FEATURE STORIES

History’s Blue Print For The AI Investment Cycle

Artificial intelligence remains a polarising subject, but Australia is strategically well positioned to benefit. So, how should investors be positioned in the AI cycle?

Oct 01 2026